Intermittent rifampicin treatment in experimental tuberculosis.
D000284:Administration, Oral; D000372:Agglutination Tests; D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis; D001770:Blood Bactericidal Activity; D003298:Coombs Test; D004195:Disease Models, Animal; D005455:Fluorescent Antibody Technique; D006168:Guinea Pigs; D007538:Isoniazid / Q000008:administration & dosage; D012293:Rifampin / Q000008:administration & dosage*; D013154:Spleen / Q000382:microbiology; D013997:Time Factors; D014374:Tuberculin Test; D014376:Tuberculosis / Q000188:drug therapy* / Q000276:immunology
D000907:Antibodies, Bacterial; D007538:Isoniazid; D012293:Rifampin